Agilent Technologies, Inc. (A)

Market Cap	41.23B +28.2%
Revenue (ttm)	7.23B +9.1%
Net Income	1.41B +21.3%
EPS	4.98 +22.7%
Shares Out	282.43M
PE Ratio	29.29
Forward PE	23.10
Dividend	$1.02 (0.70%)
Ex-Dividend Date	Jun 30, 2026

Volume	1,525,215
Open	141.43
Previous Close	141.34
Day's Range	140.85 - 146.16
52-Week Range	108.35 - 160.27
Beta	1.23
Analysts	Buy
Price Target	159.32 (+9.15%)
Earnings Date	Aug 26, 2026

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 18, 1999
• Employees: 18,100
• Stock Exchange: NYSE
• Ticker Symbol: A
• Website: https://www.agilent.com

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Analyst Summary

According to 21 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $159.32, which is an increase of 9.15% from the latest price.

Price Target

$159.32

(9.15% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 8, 2026

Data Sources Report a data error